Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

The Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials is offering a grant opportunity (R01 Clinical Trial Required) that invites applications from researchers. The purpose of this grant is for the development and execution of Phase Ib to III clinical trials. These trials will focus on testing both pharmacological (drug-based) and non-pharmacological interventions. The main aim of these interventions is to potentially prevent, postpone, or treat the symptoms of Alzheimer's disease and other age-related dementias. This grant opportunity is specifically utilizing the trial coordination and management infrastructure provided by the Alzheimer's disease Clinical Trials Consortium (ACTC).